A COMBINATION FORMULA REPRESENTING A BETTER CHOICE FOR "PCOS"
The Combined therapy with myo-inositol and D-Chiro-Inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
-M. Nordio, E. Proietti
In conclusion, we suggest that a combined therapy of Myo-Inositol plus D-Chiro-Inositol may be the first line approach treatment in PCOS overweight patients who need to control insulin levels and increase ovarian MI content, reducing the risk of developing a metabolic disease.